- Home
- » Tags
- » Quinelorane
Top View
- Distinct Temporal Phases in the Behavioral Pharmacology of LSD: Dopamine D2 Receptor-Mediated Effects in the Rat and Implications for Psychosis
- View Full Page
- Marrakesh Agreement Establishing the World Trade Organization
- (12) United States Patent (10) Patent No.: US 6,750,235 B1 Rosenbaum (45) Date of Patent: Jun
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Dopaminergic Modulation of Short-Term Synaptic Plasticity at Striatal Inhibitory Synapses
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- In Silico Studies Targeting G-Protein Coupled Receptors for Drug Research Against Parkinson’S Disease
- (12) United States Patent (10) Patent No.: US 9.248,185 B2 Rubin Et Al
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Non-Lipid Benzofuran Ethanolamine Structures
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- Pharmaabkommen A1 E
- Customs Tariff - Schedule Xxi - 1
- Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants
- II. Molecular Docking, Spectral Data-Activity Relationship
- Problems of Drug Dependence 1999: Proceedings of the 61St Annual Scientific Meeting the College on Problems
- Human Neurogenesis Assay: Ramelteon
- Dopamine Receptors
- Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- (12) United States Patent (10) Patent No.: US 7,678,808 B2 Barlow Et Al
- Supplementary Material
- Moreira and Cordeiro-MS
- Yawning.Txt 24/10/09 20:55
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Contributions of Dopamine D1, D2, and D3 Receptor Subtypes to the Disruptive Effects of Cocaine on Prepulse Inhibition in Mice
- Induction of Dopamine D3 Receptor Expression As a Mechanism
- (12) United States Patent (10) Patent No.: US 8,697,361 B2 Johnson (45) Date of Patent: Apr
- WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
- Monograph Series
- Known Bioactive Library: LOPAC 1
- Schedule Clxxiii - European Union
- The Antidepressive Effect of Barakol in the Forced-Swimming Test
- Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior